Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial crawled date : 2021 - 06 - 23 save search
BioVie Receives FDA Guidance for Phase 3 Clinical Trial of BIV201 in HRS-AKICompany Planning a Potentially Pivotal Study in This Life-Threatening Complication of Ascites
Published: 2021-06-23 (Crawled : 23:00) - biospace.com/
BIVI | $0.5025 2.18% 2.13% 850K
|
Health Technology
|
| O: 0.65%
H: 2.05%
C: -0.88%
fda potential phase 3 trial
AGTC to Host Conference Call on June 24 at 8:00 AM ET to Discuss Achromatopsia 12-Month Data in its Ongoing CNGB3 and CNGA3 Phase 1/2 Clinical Trials
Published: 2021-06-23 (Crawled : 21:00) - biospace.com/
OTIC | $0.077
|
Health Technology
|
| O: 0.92%
H: 2.73%
C: 2.27%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 2.17%
H: 0.0%
C: -1.42%
ongoing clinical trials phase 1 trial conference
AGTC to Host Conference Call to Discuss Achromatopsia 12-Month Data in its Ongoing Phase 1/2 Clinical Trials
Published: 2021-06-23 (Crawled : 21:00) - agtc.com
OTIC | $0.077
|
Health Technology
|
| O: -0.89%
H: 3.14%
C: 1.35%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 5.28%
H: 4.56%
C: -1.59%
ongoing clinical trials phase 1 trial conference phase 2 phase 3
Rubius Therapeutics Announces First Patient Dosed with RTX-240 in Combination with KEYTRUDA® (pembrolizumab) in Ongoing Phase 1/2 Clinical Trial for the Treatment of Advanced Solid Tumors
Published: 2021-06-23 (Crawled : 21:00) - biospace.com/
RUBY | $0.057 -99.3% 760K
|
Health Technology
|
| O: -0.81%
H: 2.24%
C: 1.02%
treatment solid tumors ongoing phase 1 trial phase 2 keytruda
Genprex Announces Initiation of its Phase 1/2 Acclaim-1 Clinical Trial for REQORSA™ Immunogene Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer Following FDA Review
Published: 2021-06-23 (Crawled : 18:00) - biospace.com/
GNPX | $2.31 6.77% 20K
|
Health Technology
|
| O: 5.45%
H: 11.78%
C: 6.9%
fda lung cancer phase 1 gene therapy therapy cancer trial
PureTech Founded Entity Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety and Tolerability of KarXT in Healthy Elderly Volunteers
Published: 2021-06-23 (Crawled : 18:00) - biospace.com/
KRTX | $329.83 0.0% 1.9M
|
Health Technology
|
| O: 1.44%
H: 2.4%
C: -5.38%
phase 1 results trial phase 1b phase 2b
GT Biopharma Announces Interim GTB-3550 Trike™ Monotherapy Clinical Trial Results At 2021 Raymond James Human Health Innovation Conference
Published: 2021-06-23 (Crawled : 18:00) - biospace.com/
GTBP | $3.65 -2.44% 370
|
Manufacturing
|
| O: 0.13%
H: 7.29%
C: -1.29%
biopharma therapy results trial trial results conference
Medtronic Announces Real-World Data on InPen™ and Extended Infusion Set* Pivotal Trial Data at the American Diabetes Association 81st Scientific Sessions
Published: 2021-06-23 (Crawled : 18:00) - biospace.com/
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: 0.01%
H: 0.14%
C: -0.99%
diabetes trial
Join Science 37 for a Panel of Health Industry Leaders Exploring “Decentralized Clinical Trials and the Empowered Patient Trial Experience” at Reuters Webinar
Published: 2021-06-23 (Crawled : 17:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.59%
H: 0.02%
C: -1.01%
clinical trials trial
DURECT Corporation Presents Additional Clinical Data from DUR-928 Phase 1b Trial in NASH and Phase 1 Trial in Hepatic Impairment at the International Liver Conference 2021 (EASL)
Published: 2021-06-23 (Crawled : 16:00) - biospace.com/
DRRX | $0.9071 7.55% 7.02% 130K
|
Health Technology
|
| O: 0.59%
H: 1.18%
C: -1.18%
phase 1 nash liver trial conference phase 2 phase 1b hepatitis phase 2b
Alterity Therapeutics Limited Received European Union Regulatory Guidance for ATH434 Phase 2 Clinical Trial
Published: 2021-06-23 (Crawled : 16:00) - biospace.com/
ATHE | $2.33 9.39% 8.58% 170K
|
Health Technology
|
| O: 7.69%
H: 0.71%
C: -6.43%
phase 2 europe trial ath434
JanOne Readies Clinical Supply of Lead Product Candidate JAN101 for Distribution to Phase 2b Trial Sites
Published: 2021-06-23 (Crawled : 14:15) - janone.com
JAN | $4.75 5.21% 4.95% 190K
|
Industrial Services
|
| O: -2.04%
H: 11.84%
C: -3.51%
phase 2 distribution phase 2b trial
Insights on the Industrial Ethernet Global Market to 2027 - Featuring Huawei Technologies, ABB and Belden Among Others
Published: 2021-06-23 (Crawled : 14:00) - prnewswire.com
ROK | News | $275.56 -0.28% 0.0% 600K
|
Producer Manufacturing
|
| O: 0.29%
H: 1.23%
C: -0.07%
CSCO | News | $48.33 0.02% 0.02% 14M
|
Technology Services
|
| O: 0.02%
H: 0.04%
C: -0.96%
trial
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Athira Pharma (ATHA) Investors to Contact Firm's Attorneys Now, Firm Investigating Possible Securities Law Violations
Published: 2021-06-23 (Crawled : 14:00) - prnewswire.com
ATHA | $2.02 -0.98% -0.99% 78K
|
Health Technology
|
| O: 1.06%
H: 3.73%
C: 1.53%
trial
Medicenna Announces Submission of Clinical Trial Application in Australia for a Phase 1/2 Study of MDNA11
Published: 2021-06-23 (Crawled : 13:00) - globenewswire.com
MDNA | $0.157 -0.32% 1.3M
|
Health Technology
|
| O: 2.68%
H: 0.0%
C: -9.4%
phase 1 trial submission phase 2 phase 3 application
XBiotech Announces First Patient Enrolled in Clinical Trial Evaluating XB2001 for the Treatment of Pancreatic Cancer
Published: 2021-06-23 (Crawled : 13:00) - globenewswire.com
XBIT | $8.075 -1.28% -1.3% 65K
|
Health Technology
|
| O: -0.12%
H: 1.73%
C: 1.17%
treatment cancer biotech iot trial pancreatic pancreas enroll
Cocrystal Pharma Completes IND-enabling Studies with CC-42344 for the Treatment of Seasonal and Pandemic Influenza A, Plans to initiate a Phase 1 Trial in the Third Quarter
Published: 2021-06-23 (Crawled : 12:15) - globenewswire.com
COCP | $1.562 -1.39% 3.9K
|
Health Technology
|
| O: 0.0%
H: 2.67%
C: 2.29%
treatment phase 1 influenza trial cc-42344
Glycomine Closes $68 Million Series B to Advance into Clinical Trials a Novel Treatment for PMM2-CDG, a Rare Glycosylation Disease
Published: 2021-06-23 (Crawled : 12:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.59%
H: 0.02%
C: -1.01%
disease treatment clinical trials trial rare
Editas Medicine Announces Enrollment of the First Pediatric Cohort in the BRILLIANCE Clinical Trial of EDIT-101 for the Treatment of LCA10 Following IDMC Endorsement
Published: 2021-06-23 (Crawled : 12:00) - biospace.com/
EDIT | News | $5.355 -1.92% -1.96% 1.6M
|
Health Technology
|
| O: 0.0%
H: 5.03%
C: 3.87%
treatment trial enroll
Clovis Oncology Announces LuMIERE Clinical Trial Evaluating Novel Peptide-Targeted Radionuclide Therapy FAP-2286 Now Open for Enrollment
Published: 2021-06-23 (Crawled : 12:00) - biospace.com/
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 0.34%
H: 5.42%
C: 4.58%
therapy trial enroll
Gainers vs Losers
| 65% | 35% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 210M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.